CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
4 research outputs found
Nilotinib 300 Mg Twice Daily as First Line Treatment of Ph Positive Chronic Myeloid Leukemia In Chronic Phase Updated Results of the ICORG 0802 Phase 2 Study with Analysis of the GeneXpert System Versus IS BCR ABL RQ PCR
Author
Conneally E.
Dwyer M.O.
+9Â more
Egan K.
Giles F.J.
Langabeer S.
Le Coutre P.
McDowell C.
McMullin Mary Frances
Moulton B.
Swords R.T.
Wieczorkowska M.
Publication venue
Publication date
01/12/2010
Field of study
No full text
Queen's University Belfast Research Portal
Nilotinib 300 Mg Twice Daily Is Effective and Well Tolerated as First Line Treatment of Ph-Positive Chronic Myeloid Leukemia in Chronic Phase: Preliminary Results of the ICORG 0802 Phase 2 Study
Author
Conneally E.
Egan K.
+10Â more
Giles F.
Kent E.
Langabeer S.
Le Coutre P.
McMullin Mary Frances
Moulton B.
O'Dwyer M.C.
Padmanabhan S.
Parker M.
Swords R.T.
Publication venue
Publication date
01/12/2009
Field of study
No full text
Queen's University Belfast Research Portal
38 - Enasidenib (AG-221), A Selective Oral Inhibitor of Mutant Isocitrate Dehydrogenase 2 (IDH2) Enzyme, In Patients with Myelodysplastic Syndromes (MDS)
Author
Amatangelo  M.
Attar  E.C.
+16Â more
Collins  R.
de Botton  S.
DiNardo  C.D.
Fathi  A.T.
Gupta  I.
Kantarjian  H.M.
Knight  R.D.
Pollyea  D.A.
Roboz  G.J.
Sekeres  M.A.
Stein  E.M.
Stone  R.M.
Swords  R.T.
Tallman  M.S.
Tosolini  A.
Xu  Q.
Publication venue
Elsevier Ltd
Publication date
01/04/2017
Field of study
No full text
Crossref
University of Miami: Scholarship Miami
Pharmaceutical Inhibition of Neddylation as Promising Treatments for Various Cancers
Author
An H.
Bhatia S.
+96Â more
Broemer M.
Brownell J.E.
Chen P.
Chen Y.
Cope G.A.
Ehrentraut S.F.
El Motiam A.
Enchev R.I.
Fernández-Ramos D.
Gan-Erdene T.
Gao F.
Guihard S.
Haichao Zhu
Hammill J.T.
Hammill J.T.
Harper J.W.
He S.
Hrecka K.
Hua W.
Huang D.T.
Huang G.
Jazaeri A.A.
Jia L.
Jiang Y.
Jin Y.
Kamitani T.
Kandala S.
Kuo K.L.
Kurz T.
Leung C.H.
Li L.
Li L.
Lin J.J.
Lina Yin
Liu N.
Lockhart A.C.
Loftus S.J.
Lu P.
Lu P.
Lukkarila J.L.
Luo Z.
Luo Z.
Ma H.
Ma T.
Mansouri S.
Mathewson N.
McLarnon A.
McMillin D.W.
Meihua Liu
Mizutani T.
Mo Z.
Nawrocki S.T.
Nekorchuk M.D.
Noguchi K.
Oved S.
Paiva C.
Pan W.W.
Qiannan Shang
Qingzhong Hu
Rabut G.
Rabut G.
Richardson K.S.
Sarantopoulos J.
Schlierf A.
Scott D.C.
Scott D.C.
Shah J.J.
Shamay M.
Soucy T.A.
Swords R.T.
Swords R.T.
Vanderdys V.
Wang X.
Wang Y.
Wei D.
Wu J.T.
Wu K.J.
Xirodimas D.P.
Xu J.
Yang J.
Yao W.T.
Yingxiang Liu
Yu J.
Yuanyuan Xue
Zhang S.
Zhong H.J.
Zhong H.J.
Zhong H.J.
Zhong H.J.
Zhou H.
Zhou H.
Zhou L.
Zhou W.
Zou J.
Zubiete-Franco I.
Zuo W.
Publication venue
'Bentham Science Publishers Ltd.'
Publication date
Field of study
No full text
Crossref